By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Pacira Pharmaceuticals, Inc. 

10450 Science Center Drive

San Diego  California  92121  U.S.A.
Phone: 858-625-2414 Fax: 858-678-3999



Company News
Pacira (PCRX) Release: New Study Finds Decreased Opioid Use, Hospital Stay, And Readmission Rates With EXPAREL Following Knee Replacement Surgery 11/6/2015 12:13:49 PM
Pacira (PCRX) Seeks Court Injunction To Defend Its Rights To Share Information About EXPAREL Consistent With Its FDA-Approved Indication 9/9/2015 11:34:43 AM
Pacira (PCRX) Appoints James B. Jones, MD, PharmD, As Senior Vice President And Chief Medical Officer 8/19/2015 7:34:03 AM
Pacira (PCRX) To Present At Investor Conferences In August 8/3/2015 10:44:13 AM
Pacira (PCRX) Reports Second Quarter 2015 Financial Results 7/30/2015 11:27:45 AM
Pacira (PCRX) Announces Timing For Second Quarter 2015 Financial Results Webcast And Conference Call 7/15/2015 10:51:08 AM
Pacira (PCRX) Appoints Scott Braunstein, MD, To Oversee Strategy And Corporate Development 7/14/2015 11:42:07 AM
Pacira (PCRX) Announces Completion Of End-of-Review Process With FDA Regarding EXPAREL sNDA For Nerve Block 5/28/2015 10:39:39 AM
Pacira (PCRX) To Present At Investor Conferences In June 5/21/2015 12:07:40 PM
Pacira (PCRX) Announces New Data Supporting Clinical And Pharmacoeconomic Utility Of EXPAREL In Patients Undergoing Various Surgical Procedures 5/20/2015 1:24:50 PM